Pressure Mounts On Pharma To Act On Environmental Targets
There are growing demands from government officials, investors and employees for the pharmaceutical industry to reduce emissions and waste, and – most of all – make environmental sustainability a core part of its business. To satisfy a growing concern among investors about climate change, Teva Pharmaceuticals two years ago sold $7.5bn in bonds that were […]
Tech-Powered War on AMR

The following article first ran in BioSpectrum Asia on July 4, 2023 The consistent increase in antimicrobial resistance (AMR) is threatening to undo many of the gains of modern medicine. The situation is particularly alarming in the Asia Pacific region, which could witness around 50 per cent of global annual AMR-related mortality by 2050. In […]
New Pricing Policies Needed To Curb AMR Impact, States Industry Alliance Report

Medicines For Europe Echoes Report Recommendations 22 February 2023 Executive Summary The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance. A recent report has highlighted several market reforms needed to secure essential antibiotics against the threat of antimicrobial resistance, by strengthening the […]
The Free Market is Failing Us on Antibiotics

This article first appeared in Marketplace on 22 December 2022. Researchers at Harvard Medical School in 2016 recorded a now-famous demonstration with E. coli bacteria — a species often behind recalls of contaminated food.
Antimicrobial Resistance: The Silent Pandemic

Antimicrobial Resistance: The Silent Pandemic was produced by Citi GPS: Global Perspectives and Solutions in December 2022
The Global Pharmaceutical Industry Must Play a Key Role in AMR Mitigation

Antibiotics are essential medicines that have revolutionized modern healthcare, but the rise of antimicrobial resistance (AMR) is threatening their effectiveness. Antibiotics have delivered a major impact on global life expectancy at birth; it is estimated that they may save up to 200,000 lives annually in the United States of America alone.
The Role of the Environment in the Fight Against AMR

This article originally appeared in The Guardian on November 10, 2022 Much of the global coordination on combatting AMR has rightly been focused on incentives, appropriate use, stewardship, diagnostics and other tools. But we must also consider the environmental dimension of antimicrobial resistance.
How India Can Nip the Looming Threat of Antimicrobial Resistance in the Bud

This article was originally published in Economic Times on September 11, 2022. Synopsis Read more at: https://economictimes.indiatimes.com/opinion/et-commentary/how-india-can-nip-the-looming-threat-of-antimicrobial-resistance-in-the-bud/articleshow/94137862.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Tackling the Silent Pandemic: AMR Industry Alliance Sets the Standard

This piece first appeared in European Pharmaceutical Review on 17 August 2022. Here AMR Industry Alliance representatives Melissa Gong Mitchell and Steve Brooks discuss how the Alliance is mobilising the life sciences sector in combatting antimicrobial resistance (AMR). They present the newly established antibiotics manufacturing standard that aims to minimise pharma’s contribution to AMR in […]
Research Calls for Regulators to Accelerate the Approval of Antibiotics

Report by One Health Trust says acknowledging antimicrobial resistance in regulatory frameworks for accelerated drug approval could improve access to new antibiotics.